Archives
-
Shh, Fgf10 and Species-Specific Penile Development
2026-10-02
A 2025 Cells study combines comparative embryology, gene-expression profiling, and genital-tubercle explant perturbation to explain why guinea pigs form an open urethral groove whereas mice primarily canalize a tubular urethra. Its results implicate differential Shh and Fgf10/Fgfr2 signaling in coordinating urethral morphogenesis and preputial development, while also defining important limits for translating mouse findings to human development.
-
Methyl-β-cyclodextrin Workflow Guide
2026-10-01
Methyl-β-cyclodextrin (SKU C6939) supports controlled membrane cholesterol extraction and related studies of membrane organization, fluidity, and cholesterol-dependent signaling. It is intended for laboratory research only, not for diagnostic, therapeutic, or medical use, and experimental concentration, exposure, and vehicle conditions should be optimized with membrane-integrity controls.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-10-01
A 2024 bioRxiv study shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can stabilize an activation-loop conformation that accelerates dephosphorylation by WIP1. Biochemical experiments and X-ray structures provide a framework for designing inhibitors that combine active-site inhibition with phosphatase-facilitated pathway shutdown.
-
Pcbp1, Mitochondria, and B-Cell Antibody Responses
2026-09-30
The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator that preserves mitochondrial integrity, global translation, and antibody production in B cells. Its mechanistic link to Fdxr mRNA, complex I assembly, mitochondrial reactive oxygen species, and germinal center function provides a framework for studying how metabolic and translational defects shape humoral immunity.
-
PTT and CD47 Blockade in Oral Squamous Cell Carcinoma
2026-09-30
A 2026 study shows that photothermal therapy (PTT) strengthens CD47 blockade in oral squamous cell carcinoma by combining calreticulin-mediated phagocytic signaling with extracellular-matrix remodeling. The work provides a mechanistic framework in which tumor cells display an “eat me” signal while the remodeled tumor environment enables macrophages to reach them.
-
Phosbind Acrylamide for Mechanistic Phospho-Gels
2026-09-29
Phosbind Acrylamide converts phosphorylation-dependent mobility changes into a practical mechanistic readout during SDS-PAGE. This guide connects phosphate-binding gel chemistry with the Mitotic Checkpoint Complex study and shows how to design controls that distinguish phosphorylation, protein abundance, and ubiquitin-dependent regulation.
-
4-Ethylphenyl Sulfate–Albumin Binding
2026-09-29
A 2026 Protein Science study combines spectroscopy, calorimetry, molecular docking, molecular dynamics, and MM/GBSA analysis to define how 4-ethylphenyl sulfate binds human serum albumin. The results identify interactions at both Sudlow Sites I and II, clarifying why this protein-bound uremic toxin can resist dialysis removal and informing adsorbent or displacement strategies.
-
Phenacetin for PK and Intestinal Organoids
2026-09-28
Phenacetin, also called N-(4-ethoxyphenyl)acetamide, is a research-use non-opioid analgesic and antipyretic with no anti-inflammatory activity. Its defined solvent profile and historical pharmacology support controlled pharmacokinetic studies, including exploratory work with human intestinal organoid models.
-
YAP–TEAD Super-Enhancer Control in Surface Ectoderm
2026-09-28
This study maps super-enhancer activity during pluripotent stem-cell differentiation toward surface ectoderm and links enhancer architecture to target-gene regulation. Perturbation experiments identify YAP–TEAD signaling as a regulator of early super-enhancer establishment and commitment, offering a framework for testing how noncoding regulatory elements shape epithelial lineage development.
-
Dual Enzyme-Responsive Peptides for Cancer Selectivity
2026-09-27
A 2026 study reports a zwitterionic peptide amphiphile designed for sequential MMP-7-triggered disassembly and cathepsin B-instructed assembly in cancer-cell lysosomes. The authors report low-micromolar activity, a cancer selectivity index of 64.1, and tumor regression in an HT-29 xenograft model, while the available evidence remains specific to the tested systems.
-
Nigericin Sodium Salt: Practical Lab Guide
2026-09-26
Nigericin sodium salt is a potassium ionophore for experimentally altering K+/H+ exchange, ion gradients, and cytoplasmic pH in controlled research assays. It is suitable for research workflows that can control solvent and ionic conditions, but it should not be used as a diagnostic or therapeutic agent or treated as evidence of lead-intoxication treatment efficacy.
-
Phalloidin B7678: Practical F-Actin Workflow
2026-09-25
Phalloidin is a high-affinity F-actin binder for stabilizing filament structure and supporting endpoint cytoskeleton visualization in fixed or permeabilized samples. It is not a fluorescent label by itself, and it is unsuitable for live-cell imaging or experiments that require reversible actin remodeling.
-
How Fasting Rewires Translation and Tumor Growth
2026-09-25
Yang et al. show that fasting can suppress global protein synthesis while selectively increasing eIF4E-dependent translation of liver mRNAs needed for ketone production. Their findings identify a fatty-acid–AMPK–MNK–eIF4E signaling route and suggest that inhibiting phosphorylated eIF4E can restrain pancreatic tumor growth in a ketogenic-diet context.
-
A-1210477: MCL-1 Inhibitor Research Guide
2026-09-24
A-1210477 is a potent, selective MCL-1 inhibitor for studying BIM displacement and apoptosis induction in MCL-1-dependent cancer cells. Its reported binding affinity supports in vitro pathway studies, but supplier information flags unfavorable pharmacokinetics and does not establish in vivo suitability.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-09-24
This study links hypoxia-driven lactate accumulation to ALDOB lactylation at K87, DRP1-dependent mitochondrial fission, and pulmonary artery smooth muscle cell remodeling. Its findings identify a metabolic signaling axis for further investigation, while leaving key questions about model generalizability and therapeutic relevance open.